Quick Hits

Presented by Kirsten Tangedal, Zack Dumont, & Dr. Tessa Laubscher
Objective #1

Describe how ultra-long-acting basal insulins and non-steroidal MR antagonists compare with their respective drug classes and how these differences can influence their therapeutic effects in type 2 diabetes.

Objective #2

Illustrate strategies to start or switch to a weekly basal insulin in the management of type 2 diabetes.

Objective #3

Identify practical considerations of using non-steroidal mineralocorticoid receptor (nsMR) antagonists in the setting of diabetic nephropathy in type 2 diabetes.

Objective #4

Determine when beta-blockers are no longer indicated post myocardial infarction and identify patients who are ideal candidates for discontinuing beta-blocker therapy.

Objective #5

Define when combinations of antiplatelet and anticoagulation medications are indicated in cardiovascular disease and identify patients who are ideal candidates for anticoagulation monotherapy.

Objective #6

Discuss evidence highlights from the latest data syntheses about the risks and benefits of testosterone replacement therapy.

Objective #7

Compare and contrast the new and tried, tested, and true approaches for the treatment of erectile dysfunction.